- Home
- UUU vs BOLT Comparison
UUU vs BOLT Comparison
Compare UUU & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- BOLT
- Stock Information
- Founded
- UUU 1969
- BOLT 2015
- Country
- UUU United States
- BOLT United States
- Employees
- UUU N/A
- BOLT N/A
- Industry
- UUU Electronic Components
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- UUU Technology
- BOLT Health Care
- Exchange
- UUU Nasdaq
- BOLT Nasdaq
- Market Cap
- UUU 8.3M
- BOLT 9.4M
- IPO Year
- UUU N/A
- BOLT 2021
- Fundamental
- Price
- UUU $7.22
- BOLT $4.89
- Analyst Decision
- UUU
- BOLT Buy
- Analyst Count
- UUU 0
- BOLT 3
- Target Price
- UUU N/A
- BOLT $47.50
- AVG Volume (30 Days)
- UUU 3.5M
- BOLT 14.3K
- Earning Date
- UUU 08-19-2025
- BOLT 08-14-2025
- Dividend Yield
- UUU N/A
- BOLT N/A
- EPS Growth
- UUU N/A
- BOLT N/A
- EPS
- UUU 1.19
- BOLT N/A
- Revenue
- UUU $22,789,285.00
- BOLT $4,167,000.00
- Revenue This Year
- UUU N/A
- BOLT N/A
- Revenue Next Year
- UUU N/A
- BOLT N/A
- P/E Ratio
- UUU $5.42
- BOLT N/A
- Revenue Growth
- UUU 30.84
- BOLT N/A
- 52 Week Low
- UUU $1.11
- BOLT $4.59
- 52 Week High
- UUU $7.40
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- UUU 84.65
- BOLT 37.48
- Support Level
- UUU $3.13
- BOLT $4.81
- Resistance Level
- UUU $7.10
- BOLT $5.28
- Average True Range (ATR)
- UUU 0.67
- BOLT 0.27
- MACD
- UUU 0.40
- BOLT -0.01
- Stochastic Oscillator
- UUU 89.24
- BOLT 34.84
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.